Claire Friedman, MD
Gynecologic Medical Oncologist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Immunotherapy
- Early-Phase Clinical Trials
- Uterine Cancer (Endometrial Cancer)
About Me
- Assistant Attending Physician
I am a medical oncologist who specializes in treating gynecologic cancers. These include uterine (endometrial) cancer, uterine sarcoma, ovarian cancer, and cervical cancer.
I have particular expertise in using immunotherapy to treat these diseases. I rely on a shared decision-making approach with my patients to provide their care, and I cherish the relationships I have with them and their families.
Read more
Immunotherapy is an exciting, relatively new treatment approach that takes advantage of our bodies’ own cancer-fighting abilities. It has been effective in treating some cancers, including melanoma, bladder cancer, and non-small cell lung cancer. I am studying how we can effectively use certain immunotherapies to treat gynecologic cancers.
When I meet with women who have been diagnosed with a gynecologic cancer, they are often concerned about how their treatments will affect their lives. That’s why I start by asking what’s most important to them. From there, we can have an honest discussion about what to expect.
I also remind my patients that their care team is just a phone call away if they have any concerns. I encourage questions and discussion, and want people to leave my office feeling comfortable and confident in their care plan.
A gynecologic (GY-neh-kuh-LAH-jik) medical oncologist is a cancer doctor who specializes in gynecologic cancers. This includes cervical, fallopian tube, ovarian, uterine (endometrial), vaginal, and vulvar cancers.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Immunotherapy
- Early-Phase Clinical Trials
- Uterine Cancer (Endometrial Cancer)
- Uterine Sarcoma
- Ovarian Cancer
- Cervical Cancer
Education
- MD, New York University School of Medicine
Residencies
- Internal Medicine - Hospital of the University of Pennsylvania
Awards and Honors
- Young Investigator Award, American Society of Clinical Oncology (2017)
- Clinical Fellowship in Biomarkers or Mechanisms of Action, Society for Immunotherapy of Cancer (2016)
- Merit Award, American Society of Clinical Oncology (2016)
Fellowships
- Medical Oncology – Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Friedman sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Friedman
- A Phase 1 Study of LY4170156 in People With Solid Tumors
- A Phase 1/2 Study of HST-1011 Immunotherapy in People With Solid Tumors
- A Phase 1/2 Study of STAR0602 in People With Solid Tumors
- A Phase 1/2 Study of VLS-1488 in People With Various Types of Cancer
Read more
- A Phase 2 Study of Selumetinib and Olaparib or Selumetinib Alone for Ovarian and Endometrial Cancers with Certain Genetic Changes
- A Phase I Study of IMC-F106C in People with Advanced Solid Tumors Containing Specific Proteins
- Clinical Trials Co-Investigated by Dr. Friedman
- A Phase 1/2A Study of LB101 Immunotherapy in People With Solid Tumors
- A Phase I Study of RP-3500 Alone or with Talazoparib in People with Advanced Solid Tumors with Certain Genetic Mutations
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Friedman’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Claire Friedman discloses the following relationships and financial interests:
-
Aadi Bioscience, Inc.
Professional Services and Activities -
Genentech
Professional Services and Activities (Uncompensated)
-
Loxo Oncology
Professional Services and Activities -
Merck & Co Inc.
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].